Cardiac Rehabilitation in Cardiomyopathies

NCT00966303 — Not applicable, Completed, 9 participants, Fortaleza University

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

The Effectiveness of a Cardiac Rehabilitation in Patients With Cardiomyopathy

RegistryNCT00966303
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, single group, masking: single, treatment
Enrollment9 (Actual)
SponsorFortaleza University (Other); collaborators: Edson Queiroz Foundation
ConditionsCardiomyopathies
InterventionsCardiac Rehabilitation with diaphragmatic muscle training (Other)
Datesstart 2008-06-01, primary completion 2009-04-01, completion 2009-06-01, first posted 2009-08-26, last updated 2009-10-06
Locations1 site in Brazil

Related Papers Related Patents Related Grants Related Experts
All trials for Cardiomyopathies All trials of Cardiac Rehabilitation with diaphragmatic muscle training

-Summary

This quantitative study aimed to evaluate the respiratory muscle strength, pulmonary function, cardiovascular function, and impact on quality of life in patients after cardiac rehabilitation associated with the diaphragmatic muscle training.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Cardiac RehabilitationExperimentalOther: Cardiac Rehabilitation with diaphragmatic muscle training9 patients with cardiomyopathy in functional class III or IV, submitted to an 8-week program with exercises and respiratory muscle training.
  • Cardiac Rehabilitation with diaphragmatic muscle training (Other): Stretching and aerobic exercises and respiratory muscle training with a Threshold ® device, with load of 40% of the maximal inspiratory pressure (MIP), two times a week during one hour.

+Outcome measures

Primary outcomes

  • The effectiveness of a cardiac rehabilitation in patients with cardiomyopathy, evaluating the respiratory muscle strength, pulmonary function, cardiovascular function, and impact on quality of life. [8 weeks / Twice a week]

+Eligibility

Sex: All, ages: 18 Years to 60 Years

Inclusion Criteria:

* Clinical diagnosis of Cardiomyopathies in functional class III or IV (New York Heart Association)
* Aged over 18 years
* Body mass index below 30 kg/m2

Exclusion Criteria:

* Confused and depressed patients
* Cardiac instability and worsening dyspnea after initiation of treatment

+Locations (1)

FacilityCityCountryStatus
Fortaleza University - Nucleus of Integrated Medical AttentionFortaleza, CearáBrazil

+Investigators